* Celularity Inc CELU.OQ reported quarterly adjusted
earnings of
3 cents per share for the quarter ended in September. The mean
expectation of six analysts for the quarter was for a loss of 26
cents per share.
* Revenue fell 61.1% to $4.14 million from a year ago;
analysts
expected $5.74 million.
* Celularity Inc's reported EPS for the quarter was 3
cents.
* The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Celularity Inc shares had fallen by 12.1% this quarter and
lost 60.4% so far this year.
* The company reported quarterly net income of $4.8 million.
* Wall Street's median 12-month price target for Celularity
Inc is
$10.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
14 at 10:02 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.26 0.03 Beat
Jun. 30 2022 -0.26 0.32 Beat
Mar. 31 2022 -0.26 -0.48 Missed
Dec. 31 2021 -0.31 -0.03 Beat